866-997-4948(US-Canada Toll Free)

Global Antidiabetics Market Professional Survey Report 2018

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 100 Pages

This report studies the global Antidiabetics market status and forecast, categorizes the global Antidiabetics market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.
The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.
Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.
The global Antidiabetics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
Sanofi-Aventis
Takeda Pharmaceuticals
Eli Lilly
Oramed Pharmaceuticals
Boehringer Ingelheim
Merck & Co. Inc.
Novo Nordisk
Bristol-Myers Squibb
Halozyme Therapeutics
Pfizer

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Type 1 Diabetes
Type 2 Diabetes
Other

By Application, the market can be split into
Hospital Use
Clinic Use
Household
Other

The study objectives of this report are:
To analyze and study the global Antidiabetics capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Antidiabetics manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antidiabetics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Antidiabetics Manufacturers
Antidiabetics Distributors/Traders/Wholesalers
Antidiabetics Subcomponent Manufacturers
Industry Association
Downstream Vendors



Regional and country-level analysis of the Antidiabetics market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Antidiabetics Market Professional Survey Report 2018
1 Industry Overview of Antidiabetics
1.1 Definition and Specifications of Antidiabetics
1.1.1 Definition of Antidiabetics
1.1.2 Specifications of Antidiabetics
1.2 Classification of Antidiabetics
1.2.1 Type 1 Diabetes
1.2.2 Type 2 Diabetes
1.2.3 Other
1.3 Applications of Antidiabetics
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Antidiabetics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antidiabetics
2.3 Manufacturing Process Analysis of Antidiabetics
2.4 Industry Chain Structure of Antidiabetics

3 Technical Data and Manufacturing Plants Analysis of Antidiabetics
3.1 Capacity and Commercial Production Date of Global Antidiabetics Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Antidiabetics Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Antidiabetics Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Antidiabetics Major Manufacturers in 2017

4 Global Antidiabetics Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Antidiabetics Capacity and Growth Rate Analysis
4.2.2 2017 Antidiabetics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Antidiabetics Sales and Growth Rate Analysis
4.3.2 2017 Antidiabetics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Antidiabetics Sales Price
4.4.2 2017 Antidiabetics Sales Price Analysis (Company Segment)

5 Antidiabetics Regional Market Analysis
5.1 North America Antidiabetics Market Analysis
5.1.1 North America Antidiabetics Market Overview
5.1.2 North America 2013-2018E Antidiabetics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Antidiabetics Sales Price Analysis
5.1.4 North America 2017 Antidiabetics Market Share Analysis
5.2 Europe Antidiabetics Market Analysis
5.2.1 Europe Antidiabetics Market Overview
5.2.2 Europe 2013-2018E Antidiabetics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Antidiabetics Sales Price Analysis
5.2.4 Europe 2017 Antidiabetics Market Share Analysis
5.3 China Antidiabetics Market Analysis
5.3.1 China Antidiabetics Market Overview
5.3.2 China 2013-2018E Antidiabetics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Antidiabetics Sales Price Analysis
5.3.4 China 2017 Antidiabetics Market Share Analysis
5.4 Japan Antidiabetics Market Analysis
5.4.1 Japan Antidiabetics Market Overview
5.4.2 Japan 2013-2018E Antidiabetics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Antidiabetics Sales Price Analysis
5.4.4 Japan 2017 Antidiabetics Market Share Analysis
5.5 Southeast Asia Antidiabetics Market Analysis
5.5.1 Southeast Asia Antidiabetics Market Overview
5.5.2 Southeast Asia 2013-2018E Antidiabetics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Antidiabetics Sales Price Analysis
5.5.4 Southeast Asia 2017 Antidiabetics Market Share Analysis
5.6 India Antidiabetics Market Analysis
5.6.1 India Antidiabetics Market Overview
5.6.2 India 2013-2018E Antidiabetics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Antidiabetics Sales Price Analysis
5.6.4 India 2017 Antidiabetics Market Share Analysis

6 Global 2013-2018E Antidiabetics Segment Market Analysis (by Type)
6.1 Global 2013-2018E Antidiabetics Sales by Type
6.2 Different Types of Antidiabetics Product Interview Price Analysis
6.3 Different Types of Antidiabetics Product Driving Factors Analysis
6.3.1 Type 1 Diabetes Growth Driving Factor Analysis
6.3.2 Type 2 Diabetes Growth Driving Factor Analysis
6.3.3 Other Growth Driving Factor Analysis

7 Global 2013-2018E Antidiabetics Segment Market Analysis (by Application)
7.1 Global 2013-2018E Antidiabetics Consumption by Application
7.2 Different Application of Antidiabetics Product Interview Price Analysis
7.3 Different Application of Antidiabetics Product Driving Factors Analysis
7.3.1 Hospital Use of Antidiabetics Growth Driving Factor Analysis
7.3.2 Clinic Use of Antidiabetics Growth Driving Factor Analysis
7.3.3 Household of Antidiabetics Growth Driving Factor Analysis
7.3.4 Other of Antidiabetics Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Antidiabetics
8.1 Sanofi-Aventis
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Sanofi-Aventis 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Sanofi-Aventis 2017 Antidiabetics Business Region Distribution Analysis
8.2 Takeda Pharmaceuticals
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Takeda Pharmaceuticals 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Takeda Pharmaceuticals 2017 Antidiabetics Business Region Distribution Analysis
8.3 Eli Lilly
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Eli Lilly 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Eli Lilly 2017 Antidiabetics Business Region Distribution Analysis
8.4 Oramed Pharmaceuticals
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Oramed Pharmaceuticals 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Oramed Pharmaceuticals 2017 Antidiabetics Business Region Distribution Analysis
8.5 Boehringer Ingelheim
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Boehringer Ingelheim 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Boehringer Ingelheim 2017 Antidiabetics Business Region Distribution Analysis
8.6 Merck & Co. Inc.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Merck & Co. Inc. 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Merck & Co. Inc. 2017 Antidiabetics Business Region Distribution Analysis
8.7 Novo Nordisk
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Novo Nordisk 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Novo Nordisk 2017 Antidiabetics Business Region Distribution Analysis
8.8 Bristol-Myers Squibb
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Bristol-Myers Squibb 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Bristol-Myers Squibb 2017 Antidiabetics Business Region Distribution Analysis
8.9 Halozyme Therapeutics
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Halozyme Therapeutics 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Halozyme Therapeutics 2017 Antidiabetics Business Region Distribution Analysis
8.10 Pfizer
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Pfizer 2017 Antidiabetics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Pfizer 2017 Antidiabetics Business Region Distribution Analysis

9 Development Trend of Analysis of Antidiabetics Market
9.1 Global Antidiabetics Market Trend Analysis
9.1.1 Global 2018-2025 Antidiabetics Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Antidiabetics Sales Price Forecast
9.2 Antidiabetics Regional Market Trend
9.2.1 North America 2018-2025 Antidiabetics Consumption Forecast
9.2.2 Europe 2018-2025 Antidiabetics Consumption Forecast
9.2.3 China 2018-2025 Antidiabetics Consumption Forecast
9.2.4 Japan 2018-2025 Antidiabetics Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Antidiabetics Consumption Forecast
9.2.6 India 2018-2025 Antidiabetics Consumption Forecast
9.3 Antidiabetics Market Trend (Product Type)
9.4 Antidiabetics Market Trend (Application)

10 Antidiabetics Marketing Type Analysis
10.1 Antidiabetics Regional Marketing Type Analysis
10.2 Antidiabetics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antidiabetics by Region
10.4 Antidiabetics Supply Chain Analysis

11 Consumers Analysis of Antidiabetics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Antidiabetics Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures
Figure Picture of Antidiabetics
Table Product Specifications of Antidiabetics
Table Classification of Antidiabetics
Figure Global Production Market Share of Antidiabetics by Type in 2017
Figure Type 1 Diabetes Picture
Table Major Manufacturers of Type 1 Diabetes
Figure Type 2 Diabetes Picture
Table Major Manufacturers of Type 2 Diabetes
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Antidiabetics
Figure Global Consumption Volume Market Share of Antidiabetics by Application in 2017
Figure Hospital Use Examples
Table Major Consumers in Hospital Use
Figure Clinic Use Examples
Table Major Consumers in Clinic Use
Figure Household Examples
Table Major Consumers in Household
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Antidiabetics by Regions
Figure North America Antidiabetics Market Size (Million USD) (2013-2025)
Figure Europe Antidiabetics Market Size (Million USD) (2013-2025)
Figure China Antidiabetics Market Size (Million USD) (2013-2025)
Figure Japan Antidiabetics Market Size (Million USD) (2013-2025)
Figure Southeast Asia Antidiabetics Market Size (Million USD) (2013-2025)
Figure India Antidiabetics Market Size (Million USD) (2013-2025)
Table Antidiabetics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antidiabetics in 2017
Figure Manufacturing Process Analysis of Antidiabetics
Figure Industry Chain Structure of Antidiabetics
Table Capacity and Commercial Production Date of Global Antidiabetics Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Antidiabetics Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Antidiabetics Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Antidiabetics Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Antidiabetics 2013-2018E
Figure Global 2013-2018E Antidiabetics Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Antidiabetics Market Size (Value) and Growth Rate
Table 2013-2018E Global Antidiabetics Capacity and Growth Rate
Table 2017 Global Antidiabetics Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Antidiabetics Sales (K Units) and Growth Rate
Table 2017 Global Antidiabetics Sales (K Units) List (Company Segment)
Table 2013-2018E Global Antidiabetics Sales Price (USD/Unit)
Table 2017 Global Antidiabetics Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Antidiabetics 2013-2018E
Figure North America 2013-2018E Antidiabetics Sales Price (USD/Unit)
Figure North America 2017 Antidiabetics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Antidiabetics 2013-2018E
Figure Europe 2013-2018E Antidiabetics Sales Price (USD/Unit)
Figure Europe 2017 Antidiabetics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Antidiabetics 2013-2018E
Figure China 2013-2018E Antidiabetics Sales Price (USD/Unit)
Figure China 2017 Antidiabetics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Antidiabetics 2013-2018E
Figure Japan 2013-2018E Antidiabetics Sales Price (USD/Unit)
Figure Japan 2017 Antidiabetics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Antidiabetics 2013-2018E
Figure Southeast Asia 2013-2018E Antidiabetics Sales Price (USD/Unit)
Figure Southeast Asia 2017 Antidiabetics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Antidiabetics 2013-2018E
Figure India 2013-2018E Antidiabetics Sales Price (USD/Unit)
Figure India 2017 Antidiabetics Sales Market Share
Table Global 2013-2018E Antidiabetics Sales (K Units) by Type
Table Different Types Antidiabetics Product Interview Price
Table Global 2013-2018E Antidiabetics Sales (K Units) by Application
Table Different Application Antidiabetics Product Interview Price
Table Sanofi-Aventis Information List
Table Product Overview
Table 2017 Sanofi-Aventis Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Sanofi-Aventis Antidiabetics Business Region Distribution
Table Takeda Pharmaceuticals Information List
Table Product Overview
Table 2017 Takeda Pharmaceuticals Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Takeda Pharmaceuticals Antidiabetics Business Region Distribution
Table Eli Lilly Information List
Table Product Overview
Table 2017 Eli Lilly Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Eli Lilly Antidiabetics Business Region Distribution
Table Oramed Pharmaceuticals Information List
Table Product Overview
Table 2017 Oramed Pharmaceuticals Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Oramed Pharmaceuticals Antidiabetics Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product Overview
Table 2017 Boehringer Ingelheim Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Boehringer Ingelheim Antidiabetics Business Region Distribution
Table Merck & Co. Inc. Information List
Table Product Overview
Table 2017 Merck & Co. Inc. Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Merck & Co. Inc. Antidiabetics Business Region Distribution
Table Novo Nordisk Information List
Table Product Overview
Table 2017 Novo Nordisk Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Novo Nordisk Antidiabetics Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product Overview
Table 2017 Bristol-Myers Squibb Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bristol-Myers Squibb Antidiabetics Business Region Distribution
Table Halozyme Therapeutics Information List
Table Product Overview
Table 2017 Halozyme Therapeutics Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Halozyme Therapeutics Antidiabetics Business Region Distribution
Table Pfizer Information List
Table Product Overview
Table 2017 Pfizer Antidiabetics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Pfizer Antidiabetics Business Region Distribution
Figure Global 2018-2025 Antidiabetics Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Antidiabetics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Antidiabetics Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Antidiabetics Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Antidiabetics Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Antidiabetics Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Antidiabetics Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Antidiabetics Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Antidiabetics Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Antidiabetics by Type 2018-2025
Table Global Consumption Volume (K Units) of Antidiabetics by Application 2018-2025
Table Traders or Distributors with Contact Information of Antidiabetics by Region

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *